Sign in
4

Changes in Ownership

Inhibikase Therapeutics, Inc. Filed Acc 0000950170-25-007744

Options or other derivatives

  • Director acquired 70,106 shares (grant or award)
  • Director returned 70,106 shares (to the company)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
BERMAN DENNIS N Director 2025-01-21 Returned to the company · Stock Option (Right to Buy) −21,854 0 I
BERMAN DENNIS N Director 2025-01-21 Grant or award · Stock Option (Right to Buy) +21,854 21,854 I
BERMAN DENNIS N Director 2025-01-21 Returned to the company · Stock Option (Right to Buy) −1,138 0 D
BERMAN DENNIS N Director 2025-01-21 Grant or award · Stock Option (Right to Buy) +1,138 1,138 D
BERMAN DENNIS N Director 2025-01-21 Returned to the company · Stock Option (Right to Buy) −3,780 0 I
BERMAN DENNIS N Director 2025-01-21 Grant or award · Stock Option (Right to Buy) +3,780 3,780 I
BERMAN DENNIS N Director 2025-01-21 Returned to the company · Stock Option (Right to Buy) −6,667 0 I
BERMAN DENNIS N Director 2025-01-21 Grant or award · Stock Option (Right to Buy) +6,667 6,667 I
BERMAN DENNIS N Director 2025-01-21 Returned to the company · Stock Option (Right to Buy) −6,667 0 I
BERMAN DENNIS N Director 2025-01-21 Grant or award · Stock Option (Right to Buy) +6,667 6,667 I
BERMAN DENNIS N Director 2025-01-21 Returned to the company · Stock Option (Right to Buy) −30,000 0 I
BERMAN DENNIS N Director 2025-01-21 Grant or award · Stock Option (Right to Buy) +30,000 30,000 I
Loading xslF345X05/ownership.xml…